Olympus America

Press Center

Olympus Advances Less Invasive Surgical Procedures with Innovative Technology for Laparo-Endoscopic Single-Site Surgery (LESS)

CENTER VALLEY, Pa., April 22, 2009 – Olympus America Inc. formally introduced its advanced technology platform that now allows surgeons to perform minimally invasive single-site surgery through the umbilicus (bellybutton).  While traditional laparoscopic surgery offers benefits like less pain, faster recovery time, and improved cosmesis over open surgery, this single-site surgery has the potential to extend these benefits even further. The platform, introduced at the annual Society of American Gastrointestinal and Endoscopic Surgeons meeting, combines existing Olympus and Gyrus ACMI endoscopic and laparoscopic technology with the new Advanced Surgical Concepts TriPort™  access system. The platform includes the technology and devices necessary to perform abdominal surgery through just one incision in the bellybutton.

In Laparo-Endoscopic Single-Site surgery (LESS), the TriPort access system is placed into the umbilical incision of between 12-25mm, allowing single-port access for up to three surgical or imaging instruments that can be either straight or bent, flexible or articulated. After the procedure, the surgeon removes the port, allowing the natural contours of the bellybutton to help hide the surgical incision.  

Along with the TriPort, the Olympus LESS platform consists of other advanced instruments including the unique 5mm deflectable EndoEYE®, which uses digital-chip technology to place the camera on the tip of the scope, and which delivers high-quality images enabling doctors to see fine details during surgical procedures.  Olympus’ EndoEYE has a streamlined configuration, eliminating the light post and intrusive second cable. Incorporation of a deflectable tip on the EndoEYE provides surgeons with the flexibility to change the direction of their view giving them a new way to observe the anatomy. It also helps minimize potential collisions between the instruments, which is common when operating in narrow spaces. These features make the Olympus EndoEYE the only LESS instrument of its kind.  

One of the centers utilizing this advanced technology platform is Tampa General Hospital, where Dr. Sharona Ross, Assistant Professor of Surgery, has performed a number of LESS procedures. “This procedure is nearly impossible to do without the Olympus EndoEYE, which provides an exceptional digital image while being small and flexible enough to maneuver with other instruments in a small space,” said Dr. Ross. “The EndoEYE allows us to view the surgical field from multiple angles giving the surgeon the ability to completely view the surgical dissection.”

In addition to being the exclusive distributor for the ASC TriPort, Olympus is the manufacturer of a processor called the EVIS EXERA II® universal platform, which features the world’s first and only narrow band imaging (NBI™) and high-definition technologies, the next-generation of visualization which enhances minute capillaries and tissue during laparo-endoscopic procedures. Other laparoscopic tools that can be utilized with LESS surgery include HiQ+ Hand Instruments™ and the Gyrus ACMI PK Technology platform, which are designed to be an extension of the surgeon’s hand for both grasping and dissecting tissue; and SonoSurg® Ultrasonic Surgical System, which transmits ultrasonic vibrations into energy that prevents bleeding by coagulating blood as it cuts tissue.

While there is still much to be learned, single port laparoscopy represents the next step in minimally invasive surgery. Not all patients will be candidates for single incision (single port) surgery. Also, for some patients additional incisions or open surgery may be required. For additional information and photos of the Olympus deflectable EndoEYE® and the TriPort™ access system visit www.olympuspresspass.com or to arrange an interview with Dr. Ross, please contact Lisa Koen at 212-373-6099.

About Olympus Medical Systems Group
Olympus is a leader in the advancement of less invasive patient care. Olympus, which now includes surgical market leader Gyrus ACMI, provides knowledge and solutions in the areas of advanced diagnostic and therapeutic endoscopy, early-stage cancer evaluation and treatment, and innovative, less invasive surgical procedures.  Olympus is continually dedicated to elevating standards of patient care to deliver earlier detection, faster and better treatment, improved outcomes and enhanced quality of life.

Olympus is a precision technology leader, creating innovative opto-digital solutions in healthcare, life science and consumer electronics products.

Olympus works collaboratively with its customers and its affiliates worldwide to leverage R&D investment in precision technology and manufacturing processes across diverse business lines.  These include:

  • Gastrointestinal endoscopes, accessories, and minimally invasive surgical products;
  • Advanced clinical and research microscopes;
  • Lab automation systems, chemistry-immuno and blood bank analyzers and reagents;
  • Digital cameras and voice recorders.


Olympus serves healthcare and commercial laboratory markets with integrated product solutions and financial, educational and consulting services that help customers to efficiently, reliably and more easily achieve exceptional results. Olympus develops breakthrough technologies with revolutionary product design and functionality for the consumer and professional photography markets, and also is the leader in gastrointestinal endoscopy and clinical and educational microscopes.  For more information, visit www.olympusamerica.com.

On February 1, 2008, Olympus Corporation completed the acquisition of Gyrus Group PLC, a global medical device business specializing in minimally invasive surgery, including leading edge visualization and tissue management systems.



About NBI
NBI works by altering the white light source to consist of specific wavelength bands, which take advantage of the scattering and absorption properties of human tissue. This provides enhanced visual contrast of the surface structure and fine capillary patterns of the mucous membranes, which are normally difficult to distinguish. For more information, visit http://www.olympusamerica.com/msg_section/msg_endoscopy_technology.asp?technology=nbi&intCmp=ds_nbi_index